• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Merck & Co.

Asia
Pharma

Takeda-Denali, Merck-Zhifei, Shionogi—Fierce Pharma Asia

Takeda ended its partnership with Denali. Merck and Zhifei adjusted their vaccine distribution deal. Shionogi won funding from the U.S. government.
Angus Liu Apr 10, 2026 8:00am
Iran United States US-Iran conflict Iran attacks

Pharmas stress safety, drug access amid unfolding Middle East war

Mar 2, 2026 2:20pm
merck

Merck's Welireg combos deliver 1-2 punch to kidney cancer

Feb 28, 2026 10:00am
reducing people on team

Merck, working through Gardasil demand woes, cuts jobs in N.C.

Feb 27, 2026 3:00pm
Combine

Padcev-Keytruda combo wins in MIBC amid evolving landscape

Feb 27, 2026 10:00am
RSV virus

Merck seeks Enflonsia expansion to rival Sanofi, AZ's Beyfortus

Feb 19, 2026 10:40am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings